Noto earthquake insurance payout approaches US$500m: GIAJ
April 22 2024 by Heather Ng
-
SIRC 2024: This year’s key talking points
- November 1
As the who’s who of global reinsurance gather in the Lion City for the biggest renewals jamboree of the year in the region, here is a highlight of the topics that InsuranceAsia News believes are likely to dominate the discussions.
-
APAC reinsurance composite’s 2023 COR improves to 91.6%: AM Best
- September 6
Regional reinsurers saw revenue rise 8.8%, with much of the growth fuelled by China Re and its subsidiary Chaucer.
-
APAC and Africa account for 33% of US$120bn global nat cat losses: Munich Re
- July 31
The costliest natural disaster in the first half of the year is the Noto earthquake in Japan that amounted to an estimated US$10bn in losses.
-
Noto earthquake, China floods among costliest H1 2024 economic loss events: Aon
- July 19
The Noto earthquake remained the costliest event of the year to date in terms of total economic losses with more than U$17bn in direct damage, according to the broker's new cat recap report for the first six months of the year.
-
BHSI | Managing non-Asian exposure in long-tail lines
While US-exposed business can look attractive to Asian carriers, managing the volatility around the long-term results and the ability to model those losses are crucial, say BHSI’s Marc Breuil and Marcus Portbury.
-
Sedgwick | To Handle CAT Claims Well, Multi-Step Preparation is Key
When it comes to risk, it’s not a matter of “if” it’s a matter of “when” an event will occur.
-
HSBC Asset Management | Is it time to relook at Asian currency bonds?
With diversification and performance high on investors’ agendas, it seems a good time for global portfolios to revive allocations in Asian local currency bonds – including Hong Kong dollar (HKD) bonds.
-
PineBridge Investments | Why Asian insurers are exploring private credit and CLOs
The recent rollout of risk-based capital regimes across Asia calls for a closer alignment between insurers’ assets and liabilities. We explore potential ways to maintain a healthy investment yield and robust returns on regulatory capital.
